Adenosine A2A agonist CGS 21680 decreases the affinity of dopamine D2 receptors for dopamine in human striatum

Adenosine A2A receptors (A2AR) and dopamine D2 receptors (D2R) are highly concentrated in the striatum, where they are co-localized and exert reciprocal antagonistic interactions. It has been suggested that the A2R/D2R interactions might provide a therapeutic approach for basal ganglia disorders, such as Parkinson's disease, and schizophrenia. In the present work evidence is presented for the existence of an A2AR/D2R interaction in human brain by using quantitative autoradi- ography. The areas analyzed were the dorsal caudate nucleus and putamen. Parallel studies were performed in rat striatal sections. The A2AR agonist CGS 21680 was found to significantly increase IC50 values of competitive inhibition curves of the D2R/D3R antagonist [125I]iodosulpiride vs dopamine both in rat striatal and human striatal brain sections.

[1]  M. Morelli,et al.  Adenosine A2A receptor agonists increase Fos-like immunoreactivity in mesolimbic areas , 1997, Brain Research.

[2]  M. Ochi,et al.  Antiparkinsonian activity of adenosine A2A antagonists in experimental models. , 1999, Advances in neurology.

[3]  B B Fredholm,et al.  Adenosine A2A receptors modulate the binding characteristics of dopamine D2 receptors in stably cotransfected fibroblast cells. , 1996, European journal of pharmacology.

[4]  B B Fredholm,et al.  Reciprocal interactions between adenosine A2A and dopamine D2 receptors in Chinese hamster ovary cells co-transfected with the two receptors. , 1999, Biochemical pharmacology.

[5]  J. Palacios,et al.  Dopamine receptors in human brain: autoradiographic distribution of D1 and D2 sites in Parkinson syndrome of different etiology , 1989, Brain Research.

[6]  P. Hedlund,et al.  Effects of adenosine A2A receptor stimulation in vivo on dopamine D3 receptor agonist binding in the rat brain , 1999 .

[7]  J. Palacios,et al.  Adenosine A2 receptors: Selective localization in the human basal ganglia and alterations with disease , 1991, Neuroscience.

[8]  Sergi Ferré,et al.  Adenosine–dopamine receptor–receptor interactions as an integrative mechanism in the basal ganglia , 1997, Trends in Neurosciences.

[9]  U. Ungerstedt,et al.  Antagonistic interaction between adenosine A2A receptors and dopamine D2 receptors in the ventral striopallidal system. Implications for the treatment of schizophrenia , 1994, Neuroscience.

[10]  L. Agnati,et al.  Adenosine receptors and Parkinson's disease. Relevance of antagonistic adenosine and dopamine receptor interactions in the striatum. , 2001, Advances in neurology.

[11]  K. Fuxe,et al.  Adenosine A2A Agonists: A Potential New Type of Atypical Antipsychotic , 1997, Neuropsychopharmacology.

[12]  S. Ferré.  Adenosine-dopamine interactions in the ventral striatum Implications for the treatment of schizophrenia , 1997, Psychopharmacology.

[13]  K Fuxe,et al.  Activation of Adensine A1 and A2A Receptors Modulates Dopamine D2 Receptor‐Induced Responses in Stably Transfected Human Neuroblastoma Cells , 2000, Journal of neurochemistry.